This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xita, N. Articles by Georgiou, I. Search for Related Content PubMed PubMed Citation Articles by Xita, N. Articles by Georgiou, I.

Association of the (TAAAA)n Repeat Polymorphism in the Sex Hormone-Binding Globulin (SHBG) Gene with Polycystic Ovary Syndrome and Relation to SHBG Serum Levels

Division of Endocrinology (N.X., A.T.), Department of Medicine and Genetics Unit (A.C., I.G.), Department of Obstetrics and Gynecology, University of Ioannina, Ioannina 45110, Greece

Address all correspondence and requests for reprints to: Agathocles Tsatsoulis, M.D., Ph.D., FRCP, Professor of Medicine/Endocrinology, Division of Endocrinology, Department of Medicine, University of Ioannina, Ioannina 45110, Greece. E-mail: atsatsou{at}cc.uoi.gr.

SHBG levels are frequently low in women with polycystic ovary syndrome (PCOS) and may contribute to increased tissue exposure to free androgens. A (TAAAA)n repeat polymorphism in the promoter of the SHBG gene has been described recently, and its transcriptional activity has been shown to be related to the number of tandem repeats. Recent evidence also suggests that prenatal exposure to androgen excess may program for the development of the PCOS phenotype during adulthood. Our aim was to investigate the possible association of the functional (TAAAA)n polymorphism in the promoter of the SHBG gene with PCOS and its relation to SHBG levels. We studied 185 women with PCOS and 324 normal controls. Genotype analysis revealed six (TAAAA)n alleles containing 6–11 repeats. The distribution of these alleles was different in the two groups. Women with PCOS had a significantly greater frequency of longer (TAAAA)n alleles (more than eight repeats) than normal women who had shorter alleles (less than eight repeats) in higher frequency (P = 0.001). Furthermore, in the PCOS group, carriers of the longer allele genotypes had lower SHBG levels [1.17 ± 0.68 µg/dl (35.1 ± 20.5 nmol/liter)] than those with shorter alleles [1.51 ± 0.93 µg/dl (45.3 ± 28 nmol/liter P = 0.02). A novel (TAAAA)n allele, which has not been previously reported, was found in low frequency, mainly in the control population. From these results, there is evidence that there may be a genetic contribution to decreased SHBG levels frequently seen in women with PCOS. The SHBG gene may act as a susceptibility gene for PCOS and may provide the genetic link for the developmental origin hypothesis for PCOS that was recently proposed on the basis of experimental observation in prenatally androgenized sheep and primates.

Abbreviations: CI, Confidence interval; CV, coefficient of variation; FAI, free androgen index; PCOS, polycystic ovary syndrome.

This article has been cited by other articles:

				D. J. Thompson, C. S. Healey, C. Baynes, B. Kalmyrzaev, S. Ahmed, M. Dowsett, E. Folkerd, R. N. Luben, D. Cox, D. Ballinger, et al. Identification of Common Variants in the SHBG Gene Affecting Sex Hormone-Binding Globulin Levels and Breast Cancer Risk in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3490 - 3498. [Abstract] [Full Text] [PDF]

				M. Simoni, C.B. Tempfer, B. Destenaves, and B.C.J.M. Fauser Functional genetic polymorphisms and female reproductive disorders: Part I: polycystic ovary syndrome and ovarian response Hum. Reprod. Update, September 1, 2008; 14(5): 459 - 484. [Abstract] [Full Text] [PDF]

				N. Xita, I. Georgiou, L. Lazaros, V. Psofaki, G. Kolios, and A. Tsatsoulis The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype. Eur. J. Endocrinol., June 1, 2008; 158(6): 861 - 865. [Abstract] [Full Text] [PDF]

				N. Xita, I. Georgiou, L. Lazaros, V. Psofaki, G Kolios, and A. Tsatsoulis The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome Hum. Reprod., March 1, 2008; 23(3): 693 - 698. [Abstract] [Full Text] [PDF]

				A. Turk, P. Kopp, L. A. Colangelo, M. Urbanek, K. Wood, K. Liu, H. G. Skinner, and S. M. Gapstur Associations of Serum Sex Hormone Binding Globulin (SHBG) Levels with SHBG Gene Polymorphisms in the CARDIA Male Hormone Study Am. J. Epidemiol., February 15, 2008; 167(4): 412 - 418. [Abstract] [Full Text] [PDF]

				N. Kajaia, H. Binder, R. Dittrich, P. G Oppelt, B. Flor, S. Cupisti, M. W Beckmann, and A. Mueller Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome Eur. J. Endocrinol., October 1, 2007; 157(4): 499 - 507. [Abstract] [Full Text] [PDF]

				P. Ferk, N. Teran, and K. Gersak The (TAAAA)n microsatellite polymorphism in the SHBG gene influences serum SHBG levels in women with polycystic ovary syndrome Hum. Reprod., April 1, 2007; 22(4): 1031 - 1036. [Abstract] [Full Text] [PDF]

				S. I. Berndt, N. Chatterjee, W.-Y. Huang, S. J. Chanock, R. Welch, E. D. Crawford, and R. B. Hayes Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 165 - 168. [Abstract] [Full Text] [PDF]

				A. L. Eriksson, M. Lorentzon, D. Mellstrom, L. Vandenput, C. Swanson, N. Andersson, G. L. Hammond, J. Jakobsson, A. Rane, E. S. Orwoll, et al. SHBG Gene Promoter Polymorphisms in Men Are Associated with Serum Sex Hormone-Binding Globulin, Androgen and Androgen Metabolite Levels, and Hip Bone Mineral Density J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5029 - 5037. [Abstract] [Full Text] [PDF]

				M.-J. Chen, W.-S. Yang, J.-H. Yang, C. K. Hsiao, Y.-S. Yang, and H.-N. Ho Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS Hum. Reprod., September 1, 2006; 21(9): 2266 - 2271. [Abstract] [Full Text] [PDF]

				N. Xita and A. Tsatsoulis Fetal Programming of Polycystic Ovary Syndrome by Androgen Excess: Evidence from Experimental, Clinical, and Genetic Association Studies J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1660 - 1666. [Abstract] [Full Text] [PDF]

				E. Diamanti-Kandarakis and C. Piperi Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth Hum. Reprod. Update, November 1, 2005; 11(6): 631 - 643. [Abstract] [Full Text] [PDF]

				N. Xita, A. Tsatsoulis, I. Stavrou, and I. Georgiou Association of SHBG gene polymorphism with menarche Mol. Hum. Reprod., June 1, 2005; 11(6): 459 - 462. [Abstract] [Full Text] [PDF]

				H. F. Escobar-Morreale, M. Luque-Ramirez, and J. L. San Millan The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome Endocr. Rev., April 1, 2005; 26(2): 251 - 282. [Abstract] [Full Text] [PDF]

				C. A. Haiman, S. E. Riley, M. L. Freedman, V. W. Setiawan, D. V. Conti, and L. Le Marchand Common Genetic Variation in the Sex Steroid Hormone-Binding Globulin (SHBG) Gene and Circulating SHBG Levels among Postmenopausal Women: The Multiethnic Cohort J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2198 - 2204. [Abstract] [Full Text] [PDF]

				D. A. Ehrmann Polycystic Ovary Syndrome N. Engl. J. Med., March 24, 2005; 352(12): 1223 - 1236. [Full Text] [PDF]